A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GDC-0853 in Healthy Japanese and Caucasian Participants
Clinical trial NCT03188783 · COMPLETED
Trial details
- NCT number
- NCT03188783
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-24
- Primary completion
- 2017-08-09
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.